Spectranetics to Present at the Canaccord Adams 3rd Annual Cardiovascular Conference on November 10

Spectranetics Corporation (Nasdaq: SPNC) today announced that it will present at the Canaccord Adams 3^rd Annual Cardiovascular Conference on Tuesday, November 10, 2009. The conference is being held at the Nikko Hotel in San Francisco.

Emile J. Geisenheimer, Spectranetics’ chairman, president and chief executive officer, is scheduled to speak at 1:30 p.m Pacific time (2:30 p.m. Mountain time) and will discuss the Company's strategic initiatives, product pipeline and market opportunities.

Interested parties can access a live audio webcast and slide presentation at www.spectranetics.com. An archived presentation will be available on the Web site for 14 days.

About Spectranetics

Spectranetics manufactures and markets the only Excimer Laser System approved in the United States, Canada, Europe and Japan for use in minimally invasive interventional procedures within the cardiovascular system. More than 800 Spectranetics laser systems are used in hospitals worldwide.

The Company’s Vascular Intervention (VI) products include a range of peripheral and cardiac laser catheters for ablation of occluded arteries above and below the knee and within coronary arteries. The Company also markets aspiration catheters for the removal of thrombus and support catheters to facilitate crossing of coronary and peripheral arterial blockages.

The Lead Management (LM) product line includes excimer laser sheaths and cardiac lead management accessories for the removal of pacemaker and defibrillator cardiac leads.

For more information, visit www.spectranetics.com